These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Functional roles of protein kinase A (PKA) and exchange protein directly activated by 3',5'-cyclic adenosine 5'-monophosphate (cAMP) 2 (EPAC2) in cAMP-mediated actions in adrenocortical cells. Aumo L, Rusten M, Mellgren G, Bakke M, Lewis AE. Endocrinology; 2010 May; 151(5):2151-61. PubMed ID: 20233795 [Abstract] [Full Text] [Related]
24. Phosphodiesterase-4 inhibitors reduce the expression of proinflammatory mediators by human epidermal keratinocytes independent of intracellular cAMP elevation. Kataoka S, Takaishi M, Nakajima K, Sano S. J Dermatol Sci; 2020 Dec; 100(3):230-233. PubMed ID: 33109421 [No Abstract] [Full Text] [Related]
26. Mechanisms Underlying the Clinical Effects of Apremilast for Psoriasis. Pincelli C, Schafer PH, French LE, Augustin M, Krueger JG. J Drugs Dermatol; 2018 Aug 01; 17(8):835-840. PubMed ID: 30124722 [Abstract] [Full Text] [Related]
29. Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis. Bianchi L, Del Duca E, Romanelli M, Saraceno R, Chimenti S, Chiricozzi A. Expert Opin Drug Metab Toxicol; 2016 Sep 01; 12(9):1121-8. PubMed ID: 27376729 [Abstract] [Full Text] [Related]
30. Adenosine A2A-receptor stimulation inhibits lipopolysaccharide-induced interleukin-18 production in monocytes. Takahashi HK, Kanke T, Liu K, Yoshino T, Sendo T, Tanaka N, Nishibori M. J Pharmacol Sci; 2007 Jun 01; 104(2):183-6. PubMed ID: 17558181 [Abstract] [Full Text] [Related]
31. ROS/Epac1-mediated Rap1/NF-kappaB activation is required for the expression of BAFF in Raw264.7 murine macrophages. Moon EY, Lee JH, Lee JW, Song JH, Pyo S. Cell Signal; 2011 Sep 01; 23(9):1479-88. PubMed ID: 21596132 [Abstract] [Full Text] [Related]
32. PDE4 inhibition reduces neointima formation and inhibits VCAM-1 expression and histone methylation in an Epac-dependent manner. Lehrke M, Kahles F, Makowska A, Tilstam PV, Diebold S, Marx J, Stöhr R, Hess K, Endorf EB, Bruemmer D, Marx N, Findeisen HM. J Mol Cell Cardiol; 2015 Apr 01; 81():23-33. PubMed ID: 25640159 [Abstract] [Full Text] [Related]
37. 2',3'-cAMP, 3'-AMP, 2'-AMP and adenosine inhibit TNF-α and CXCL10 production from activated primary murine microglia via A2A receptors. Newell EA, Exo JL, Verrier JD, Jackson TC, Gillespie DG, Janesko-Feldman K, Kochanek PM, Jackson EK. Brain Res; 2015 Jan 12; 1594():27-35. PubMed ID: 25451117 [Abstract] [Full Text] [Related]
38. Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor alpha but not methotrexate. Varani K, Massara A, Vincenzi F, Tosi A, Padovan M, Trotta F, Borea PA. Arthritis Rheum; 2009 Oct 12; 60(10):2880-91. PubMed ID: 19790066 [Abstract] [Full Text] [Related]
39. Stimulation of adenosine A2A receptors reduces intracellular cholesterol accumulation and rescues mitochondrial abnormalities in human neural cell models of Niemann-Pick C1. Ferrante A, De Nuccio C, Pepponi R, Visentin S, Martire A, Bernardo A, Minghetti L, Popoli P. Neuropharmacology; 2016 Apr 12; 103():155-62. PubMed ID: 26631535 [Abstract] [Full Text] [Related]